Bill S-211: Recognizing June 19 as the Canadian Sickle Cell Awareness Day

Similar documents
How to Increase Awareness Lanre Tunji-Ajayi. President/Executive Director; SCDAC/AAFC

SICKLE CELL DISEASE. I have made you and I will carry you. I will sustain you and I will rescue you. - Isaiah 46:4

SICKLE CELL ANEMIA. I have made you and I will carry you. I will sustain you and I will rescue you. - Isaiah 46:4

National Sickle Cell Awareness Day Bill

Permanent Donor Deferral Policy

Your sickle cell disease story

A PERFECT STORM OF HEART DISEASE LOOMING ON OUR HORIZON 2010 HEART AND STROKE FOUNDATION ANNUAL REPORT ON CANADIANS HEALTH A PERFECT STORM 1

STRATEGIC WORKING PLAN

We are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada

Carrying Beta Thalassaemia A carrier can use this booklet to

We are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada

W H A T N A C D O E S

CHHA-NL POSITION PAPER. Universal Newborn Hearing Screening Program (UNHSP) in Newfoundland and Labrador

Notes for Remarks Dr. Jan Hux, President and Kimberley Hanson, Director, Federal Affairs Diabetes Canada. To the Standing Committee on Health

The American Society of Hematology (ASH) represents more than 17,000 clinicians and

SAVE The DATE Medical Lunch & Learns- Empowering and Educating the medical professionals Event is open to Medical professionals alone.

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION...

Report from the National Diabetes Surveillance System:

GIVING BIRTH SHOULD NOT BE A MATTER OF LIFE AND DEATH

Index. Note: Page numbers of article titles are in boldface type.

Utility of hemoglobin electrophoresis to detect hemoglobinopathies in adults not presenting with hematological problems

A Guide for Understanding Genetics and Health

Sickle Cell Disease and impact on the society

Sickle Cell Disease and Stroke

YOUR SEASONAL FLU GUIDE

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

SICKLE-CELL DISEASE IN THE AFRICAN REGION: CURRENT SITUATION AND THE WAY FORWARD. Report of the Regional Director EXECUTIVE SUMMARY

Introduction to Emergency Medical Care 1

Chapter 26 - Hematologic_and_Renal_Emergencies

5 th Annual. August 18, 2018 SPONSOR PROSPECTUS

CHAPTER 3: Modifiable risk factors and diabetes self-care

A Guide for Understanding Genetics and Health

A Guide for Understanding Genetics and Health

PSYCHOLOGIST SALARY COMPARISON October 2016

THALASSEMIA AND COMPREHENSIVE CARE

A Guide for Understanding Genetics and Health

Demand for Ocular Tissue in Canada - Final Report

SICKLE CELL BROCHURE

MATERNAL HEALTH IN AFRICA

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

CHAPTER 4: Population-level interventions

Message from our President - Ms. Doreen Alexander

Each person has a unique set of characteristics, such as eye colour, height and blood group.

CURRENT RESEARCH STUDIES

GENE THERAPY AS A SOLUTION TO SICKLE CELL DISEASE

FIGO is delighted to participate and work with The Collaborative On Health and The Environment

New Delhi Declaration

Hydroxyurea Treatment for Sickle Cell Disease

Occupational Noise Exposure

Sickle Cell Anemia. Sickle cell anemia is an inherited disorder of the blood which occurs when just one base pair substitution

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

West Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

PDF HEART DISEASE STATISTICS 2017 DOWNLOAD

OBSTETRIC FISTULA. Introduction WHEN CHILDBIRTH HARMS: 1 Updated with technical feedback December 2012

Cost-effectiveness in FASD prevention. Egon Jonsson, Institute of Health Economics, Edmonton, Alberta, Canada

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

Health Canada. Santé Canada. Tuberculosis in Canada pre-release

TUBERCULOSIS IN CANADA 2010 PRE-RELEASE

Crude health statistics

Achievements

Myths and facts: Suicide Prevention in the Workplace. Centre for Suicide Prevention November 21 st, 2017

Thalassaemia and other haemoglobinopathies

The epidemiology of HIV in Canada

March XX, Washington, DC Washington, DC Washington, DC Washington, DC 20515

Special health needs of women and children

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

Cause And Effect Essay Iron-Deficiency

Hydroxyurea Treatment for Sickle Cell Disease

SCD Advocacy Talking Points!

Poison Control Centres

Latest Funding Trends in AIDS Response

Snapshot. Make sure you have your Blood and its cells packet - you will need notes on blood cells to play a game

Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality

2017 JOB MARKET & EMPLOYMENT SURVEY EXECUTIVE SUMMARY

CONTRACEPTIVES SAVE LIVES

Screening for haemoglobinopathies in pregnancy

A Guide for Understanding Genetics and Health

NATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)

Canadian Congenital Heart Alliance 2011 Annual Report

Natural Selection In Humans (Sickle Cell Anemia)

Sickle Cell Anemia A Fictional Reconstruction Answer Key

Colorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT

XV. THE ICPD AND MDGS: CLOSE LINKAGES. United Nations Population Fund (UNFPA)

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

COLLABORATIVE STAGE TRAINING IN CANADA

Screening for sickle cell disease and thalassaemia. An easy guide to screening tests when you are pregnant

Influenza Vaccination Coverage in British Columbia Canadian Community Health Survey 2011 & 2012

Appendix B Fracture incidence and costs by province

Strategic Working Plan

RNAO response to proposed regulation under Smoke-Free Ontario Act, 2017

Thalassaemia. What is thalassaemia? What causes thalassaemia? What are the different types of thalassaemia?

Striving for better health

Disclosures. What is Palliative Care? The Role of the S-LP in Palliative Care An Overview and Interactive Discussion.

Public awareness of sickle cell disease in Bahrain

How to Write a Life Care Plan for a Child with Hemoglobinopathy

Impaired driving statistics

World Health Day 2013 Remarks of PAHO Director Carissa F. Etienne

Together. we are. stronger

Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

Transcription:

Bill S-211: Recognizing June 19 as the Canadian Sickle Cell Awareness Day

Sickle Cell Disease (SCD) is the most common genetic disease in the world. According to the World Health Organization (WHO) estimates, sickle-cell anemia affects nearly 100 million people throughout the world. Tragically, the majority of these individuals will die in childhood due to lack of basic care, and those who survive into adulthood too often face a life of chronic disability and premature death unless disease-modifying therapy can be provided. In Canada, estimated 5000 persons live with SCD and up to 25%1 of Canadians from ethnic roots in regions of the world traditionally affected by malaria may carry the trait. RECOGNITION OF SCD IN CANADA The World Health Organization (2006) and United Nations (2008) have designated the 19th day of June every year as World Sickle Cell Day (WSCD). Canada has yet to recognize this date. The province of Nova Scotia, cities of Markham and Toronto and town of Ajax (Ontario) are the only jurisdictions recognizing June 19th as WSCD. On December 8th 2015 Hon. Jane Cordy introduced Bill S-211- An Act respecting National Sickle Cell Awareness Day. This bill has passed 1st reading and is currently in 2nd reading. The World Health Organization (WHO) and the United Nations have recognized SCD as a global public health priority. The WHO therefore urges countries affected by SCD to establish health programs at the national level and promote access to medical services for people affected by the disease2 3

WHAT IS SCD? SCD or sickle cell anemia is a hereditary genetic disease characterized by the presence of abnormal crescent-shaped red blood cells. People with SCD have abnormal hemoglobin (called hemoglobin S or sickle haemoglobin) in their red blood cells. Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. The abnormal shaped red cells cause a lack of tissue oxygen, which in turn can cause sudden attacks of excruciating pain, called pain crises. These pain attacks can occur without warning, with levels of pain often described as the same or worse than childbirth labour pain and cancer related pain. The red cell sickling and poor oxygen delivery can also cause organ damage. Over a lifetime, SCD can harm a person s spleen, brain, eyes, lungs, liver, heart, kidneys, joints, bones, or skin. It can cause stroke in even children as young as two years old! At the present time, hematopoietic stem cell transplantation is the only cure for SCD. Canadians affected by sickle cell disease come from diverse ethnic backgrounds - African, Caribbean, Mediterranean, Middle East, South America, and South Asia. What is Sickle Cell Trait (SCT) People with the SCT have inherited a copy of genes for normal haemoglobin from one parent and genes for sickle cell hemoglobin from the other parent. While these individuals are not sick themselves, they run the risk of passing the gene to their own children. Sickle cell trait occurs in approximately 300 million people worldwide, with the highest prevalence of approximately 30% to 40% in sub-saharan Africa3. 4

CURRENT STATE OF SCD IN CANADA If living in Canada with SCD, you, your child or family member: May not have access to comprehensive care including lifesaving treatments, drugs and knowledgeable care providers May be stigmatized and branded as drug seekers when presenting for medical treatment for vaso-occlusive pain crises, and then denied access to effective pain medications Often have quality of life that is lower than your friends and other Canadians without SCD Have a life expectancy that is significantly reduced by about 25 to 30 years compared to other Canadians without SCD May have your children born with the condition without diagnosis until after a critical window to provide life-saving treatment has passed. This is because new born screening for SCD is not universal and currently provinces of Alberta, Manitoba, Saskatchewan, Newfoundland & Labrador and Northwest territories are not screening newborns for hemoglobinopathies. May have children born with sickle cell trait, even in provinces with newborn screening, and not be aware that they, too, are at risk of having an affected child of their own WHAT WE NEED FROM YOU: Vote in support of Bill S211- An Act Respecting June 19th as the National Sickle Cell Awareness Day 5

Bill S-211 Currently in 2nd reading, Bill S-211 was introduced by Senator Jane Cordy on December 8th 2015. It is an Act respecting National Sickle Cell Awareness Day. WHY MUST BILL S-211 PASS AS LAW? Currently Canada witnesses about 120 new births yearly and number continues to rise International migration further increases the population prevalence in Canada Canada continues to lose many youths and children to preventable complications of SCD. The first step towards reducing the number of new SCD births is increasing awareness of the disease. Establishing a national awareness day will be an important step towards identifying at risk individuals, providing them preventative care, and decreasing the burden of illness that would otherwise result for both family members and the medical system as a whole. About the SCDAC The Sickle Cell Disease Association of Canada Established in 2012, SCDAC is a national patient association advocating for comprehensive healthcare system across Canada for individuals and families with sickle cell disease (SCD). Through its educational programs, the SCDAC is improving knowledge translation among health care providers and management of SCD among patients and families. SCDAC works with governments, researchers, clinicians and industry to increase awareness of SCD and advance the current care and treatments with the goal of improving the quality of life of affected individuals and their families. References: SCAGO. (March 2007). Sickle Cell Disease within the at Risk Communities. Sickle Cell Awareness Group of Ontario. Retrieved from sicklecellanemia.ca United Nations. (December, 2008). Adopting Consensus Text, General Assembly Urges Member States, United Nations System To Raise Awareness Of Sickle Cell Anaemia On 19 June Each Year. United Nations 2014, New York. Retrieved from http://www.un.org/press/en/2008/ga10803.doc.htm Tsaras, Geoffrey. Owusu-Ansah, Amma. Owusua Boateng, Freda. Amoateng-Adjepong, Yaw. (June, 2009). Complications Associated with Sickle Cell Trait: A Brief Narrative Review.The American Journal of Medicine, Vol 122, No 6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19393983 6

Lanre Tunji-Ajayi, President and Executive Director Sickle Cell Disease Association of Canada/Association d Anémie Falciforme du Canada (SCDAC/AAFC) Unit 34, 260 Adelaide St. E, Toronto, ON M5A 1N1 Canada E-mail: president@sicklecelldisease.ca Copy: communication@sicklecelldisease.ca